Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sharps Technology Inc. (STSS:NASDAQ), powered by AI.
Sharps Technology Inc. is currently trading at $1.84. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sharps Technology Inc. on Alpha Lenz.
View Sharps Technology Inc.'s valuation metrics on Alpha Lenz.
“Sharps Technology Inc.'s ROE is -212.1%. Explore profitability and growth together.”
Ask for details →Sharps Technology Inc. is a company focused on the design and manufacture of innovative safety syringe products. Its primary function is to enhance patient and healthcare worker safety by reducing the risk of needlestick injuries and improving medication delivery systems. The company's portfolio includes patented products that offer state-of-the-art solutions to obstacles faced in the medical and pharmaceutical sectors. With a commitment to research and development, Sharps Technology Inc. plays a pivotal role in advancing needle safety protocols in health care settings. Operating in a highly regulated industry, the company impacts not only health care facilities but also pharmaceutical companies and government agencies involved in public health and safety. By addressing critical safety concerns within the medical field, Sharps Technology Inc. contributes significantly to the overall improvement of health care delivery systems. Its innovations have market significance as they potentially influence regulatory standards and guide future developments in medical safety equipment.
“Sharps Technology Inc.'s ROE is -212.1%. Explore profitability and growth together.”
Ask for details →Sharps Technology Inc. (ticker: STSS) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 55 employees.
The current price is $1.84 with a P/E ratio of -x and P/B of -x.
ROE is -212.11% and operating margin is -6512.09%. Annual revenue is $204,120.